Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry

Kellie, John F., Higgs, Richard E., Ryder, John W., Major, Anthony, Beach, Thomas G., Adler, Charles H., Merchant, Kalpana, Knierman, Michael D.·2014·Scientific Reports
DOI 10.1038/srep05797

Cited by (130)

Items 101–130 of 130

  1. Rethinking the reliability and accuracy of biomarkers in CNS-originating EVs for Parkinson's disease and multiple system atrophy
    Hash Brown Taha · 2023 · Frontiers in Neurology
  2. A Facile Method to Produce N-Terminally Truncated α-Synuclein
    Rebecca J. Thrush, Devkee M. Vadukul, F. Aprile · 2022 · bioRxiv
  3. The C-terminus of α-Synuclein Regulates its Dynamic Cellular Internalization by Neurexin 1β
    Melissa Birol, Isabella Ioana Douzoglou Muñoz, Elizabeth Rhoades · 2023 · bioRxiv
  4. Intact quantitative bioanalytical method development and fit-for-purpose validation of a monoclonal antibody and its related fab fragment in human vitreous and aqueous humor using LC-HRMS
    Catherine E. DelGuidice, Omnia A. Ismaiel, William R. Mylott Jr, Moucun Yuan, Matthew S. Halquist · 2022 · Analytical and Bioanalytical Chemistry
  5. Microfluidic platform for understanding Parkinson’s disease and α-synuclein conformation
    Pavel P. Tregub, Georgy M. Zembatov, Eugenia Namiot, Kolotyeva Natalia, Yurchenko Stanislav, Illarioshkin Sergey, Alla B. Salmina · 2025 · Translational Neurodegeneration
  6. Bioanalytical Considerations for Biomarkers of Parkinson's Disease
    Aric Huang, R. Foti, C. Geeth Gunawardana, Honglue Shen, Yingwen Xiao · 2025 · Journal of Neurochemistry
  7. Neighbouring modifications interfere with the detection of phosphorylated alpha-synuclein at Serine 129: Revisiting the specificity of pS129 antibodies
    Hilal Ahmed Lashuel, Anne‐Laure Mahul‐Mellier, Salvatore Novello, Ramanath Narayana Hegde, Yllza Jasiqi, Melek Firat Altay, Sonia Donzelli, Sean M. DeGuire, Ritwik Burai, Pedro Magalhães et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Quantitative Profiling of Synuclein Species: Application to Transgenic Mouse Models of Parkinson’s Disease
    Serena Singh, A. Khayachi, A. Milnerwood, Mari L. DeMarco · 2020 · Journal of Parkinson's Disease
  9. Cracking the code of native amyloid fibrils: advances and next steps to enable pathology-informed therapeutic and diagnostic
    Hilal Ahmed Lashuel · 2026 · Nature Structural & Molecular Biology
  10. C-terminus-dependent detection of lysosomal alpha-synuclein in nigral Parkinson’s disease human brain neurons
    Martino L. Morella, Bana Al Khayrat, Tim E. Moors, Lisanne in ‘t Veld, Irene Frigerio, Vinod Udayar, Bram van der Gaag, Wilma D. J. van de Berg · 2025 · Molecular Neurodegeneration
  11. Mass spectrometric identification of novel truncated α-synuclein species following optimized immunoprecipitation from human brain tissue
    Kim-Thanh Van, Fatimah Nabeebaccus, Foudil Lamari, Susana Boluda, François Fenaille, Nicolas Villain, François Bécher · 2025 · Analytical Biochemistry
  12. Quantitative Bioanalysis of Intact Large Molecules using Mass Spectrometry
    Catherine E. DelGuidice, Omnia A. Ismaiel, William R. Mylott, M. Halquist · 2020
  13. Hyphenations of one-dimensional capillary liquid chromatography with mass spectrometry
    Steven Ray Wilson, Henriette Engen Berg, Hanne Røberg‐Larsen, Elsa Lundanes · 2020 · Elsevier eBooks
  14. Proteoforms in Disease: Biomedical Applications of Top-Down Proteomics
    Holden T. Rogers, Z. Gregorich, Megan S. Gant, Zhan Gao, J. Chamot-Rooke, Ying Ge · 2026 · Mass spectrometry reviews (Print)
  15. Multiplex Immunofluorescent Analysis of Alpha‐Synuclein in Nigral Lewy Bodies With Heat‐Induced Antibody Stripping Reveals an Intricate Multilayered Structure
    Dominik Hraboš, Satomi Hasegawa, D. Koníčková · 2025 · Neuropathology and Applied Neurobiology
  16. Synaptic vesicle endocytosis deficits underlie GBA-linked cognitive dysfunction in Parkinson’s disease and Dementia with Lewy bodies
    D. J. Vidyadhara, D. Bäckström, Risha Chakraborty, J. Ruan, Jae-Min Park, Pramod K. Mistry, S. Chandra · 2024 · Research Square
  17. Synaptic vesicle endocytosis deficits underlie GBA-linked cognitive dysfunction in Parkinson’s disease and Dementia with Lewy bodies
    D. J. Vidyadhara, David C. Bäckström, Risha Chakraborty, Jiapeng Ruan, Jae Min Park, Pramod Kumar Mistry, Sreeganga S. Chandra · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Investigating protein conformational ensembles by native mass spectrometry and complementary biophysical techniques—the case of α-synuclein
    S. Brocca, E. Ponzini, C. Santambrogio, Rita Grandori · 2026 · Frontiers in Biophysics
  19. Differently sized soluble α-synuclein species from multiple system atrophy and Lewy body disease brains display different seeding propensities
    S. Zampar, Y. Mei, F. Samuel, M. Karadağ, I. Martínez-Valbuena, N. R. G. Silver, G. Grimmer, S. D. Di Gregorio, A. Tandon, G. Kovacs et al. · 2026 · bioRxiv
  20. Top-Down versus Bottom-Up Proteomics in Highly Sensitive LC-MS-Based Profiling of Limited Samples
    Yun-Fan Gao, Michal Greguš, James C. Kostas, Anne-Lise Marie, Alexander R. Ivanov · 2026 · Analytical Chemistry
  21. N-Terminal Amine Chemistry Influences α-Synuclein Interactions with Lipid Bilayers
    Emily A. E. Brackhahn, Ming-Hao Li, Paola Miranda-Castrodad, H. Lee, J. Musila, David Eliezer, Elizabeth Rhoades · 2026 · Biochemistry
  22. Structural biology of alpha-synuclein amyloid filaments: Implications in synucleinopathies
    Phelippe do Carmo Gonçalves, Irina Fernández, Claudio O. Fernández · 2026 · Journal of Parkinson s Disease
  23. N-terminal acetylation reduces synuclein pathology in models of Parkinson's disease
    Esther del Cid‐Pellitero, Thomas Goiran, Zaid A.M. Al‐Azzawi, Nathan C. Karpilovsky, Jace Jones-Tabah, Jonas J. Mayo, Frédérique Larroquette, Wen Luo, Irina Shlaifer, Yogitha Thattikota et al. · 2026 · Neurobiology of Disease
  24. Parkinson's disease and appendix: a hidden kinship
    Hetvi Patel, Maitry H. Rathod, Bisojeet R. Khandai, A. Vyas · 2026 · International Journal of Basic & Clinical Pharmacology
  25. Comprehensive Analysis of Autophagy-Related Gene Profiles and Immune Characteristics in Parkinson’s Disease
    Lei Yu, Meimei Guo, Shilin Zhang, Yutuo Zheng, Jiawei Hao, Yuhan Liu, Jiabin Zhou · 2026 · ACS Chemical Neuroscience
  26. Aggregation-prone alpha-synuclein proteoforms and dysregulated molecular signatures in the vermiform appendix of synucleinopathy patients
    Ehraz Anis, Saima Zameer, Josh Wierenga, Peipei Li, Jacek W. Sikora, Juozas Gordevičius, Meghan Schilthuis, Richard D. LeDuc, Jeffrey H. Kordower, Michelle A. Pinho et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Residues 2-7 of α-synuclein regulate amyloid formation via lipid-dependent and -independent pathways
    Katherine M Dewison, B. Rowlinson, Jonathan M Machin, J. Crossley, Dev Thacker, M. Wilkinson, Sabine M. Ulamec, G. N. Khan, N. Ranson, P. van Oosten-Hawle et al. · 2024 · bioRxiv
  28. Software-Assisted Data Processing Workflow for Intact Glycoprotein Mass Spectrometry
    Alan B. Moran, E. Domínguez-Vega, M. Wuhrer, G. Lageveen-Kammeijer · 2023 · Journal of Proteome Research
  29. Aggregation of alpha-synuclein using single-molecule spectroscopy
    Marija Iljina · 2017
  30. Mass spectrometric analysis of Lewy body-enriched -synuclein in Parkinson’s disease
    Payel, Bhattacharjee, Annika, Öhrfelt, Tammaryn, Lashley, Kaj, Blennow, Ann, Brinkmalm et al. · 2019